AbbVie | ABBV - Trade Creditors

Stock Price
206.67
Daily Change
-2.17 -1.04%
Monthly
-9.14%
Yearly
10.79%
Q2 Forecast
202.55

AbbVie reported $3.59B in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Abbott USD 4.12B 183M Sep/2025
ALKERMES USD 107.95M 39.95M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Biogen USD 432M 18.9M Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Coherus Biosciences USD 9.91M 14.98M Dec/2025
Eisai JPY 85.49B 4.76B Dec/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
J&J USD 11.99B 2.37B Dec/2025
Medtronic USD 2.57B 12M Dec/2025
Merck USD 4.15B 102M Sep/2025
Neurocrine Biosciences USD 545.5M 425.6M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Pacira USD 15.15M 2.54M Dec/2025
Perrigo USD 474.5M 4.8M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sanofi EUR 22.93B 927M Dec/2025
UCB EUR 4.04B 755M Dec/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
United Therapeutics USD 7.1M 460.9M Dec/2025
Vertex Pharmaceuticals USD 3.43B 600.9M Dec/2025
Zoetis USD 487M 77M Dec/2025